For PET, tumour imaging with FDG is by far the most extensively performed examination (100% of all hospitals with PET/CT; N = 17) whereas tumour imaging with Cu-64 PSMA was documented in only 18% (N = 3) of all hospitals. This evidence concerns the gene FOLH1 and neoplasm.